POZEN
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, POZEN sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).
POZEN: 24 sponsored US clinical trials, none currently recruiting.
POZEN sponsors 24 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 23 completed. 12 of these trials are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Gastric Ulcer, with 1 trials.
Top-decile sponsor footprint
POZEN ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
23 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
24 total, page 1 of 1
A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540
NCT01557335
Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers
NCT00995410
A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
NCT00961350
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
NCT00960869
A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
NCT00749385
Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib
NCT00729495
Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
NCT00692055
Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib
NCT00700687
Study Evaluating the Effect of Food on the Bioavailability of PN400 Components
NCT00676442
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
NCT00664560
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
NCT00665431
Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations
NCT00665743
Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen
NCT00527787
Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec
NCT00594854
A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)
NCT00527904
A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin
NCT00441519
An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers
NCT00442208
To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin
NCT00442052
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.
NCT00367211
Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.
NCT00293657
Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy
NCT00293631
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
NCT00433732
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
NCT00434083
The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
NCT00442221
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 2 |
| Phase 3 | 12 |
Therapeutic Areas
How the POZEN archive is shaped
24 indexed studies, none listed as recruiting (0% open); 23 completed (96%).
Phase mix: 12 late (III/IV) vs 12 early (I/II) (balanced across stages).
Top condition: Gastric Ulcer (1 trial), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
POZEN: archived-pipeline peers nationwide
Peers matched on 24 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
POZEN sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 24 archived trials
- Acrotech Biopharma · 24 trials · 8% recruiting
- Agenus · 24 trials · 0% recruiting
- Akebia Therapeutics · 24 trials · 4% recruiting
- Blueprint Medicines Corporation · 24 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this POZEN page
24 registered trials is a research-attention snapshot, not an endorsement of POZEN or any single study.
- None of POZEN's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Gastric Ulcer is the condition POZEN studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Gastric Ulcer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
POZEN pipeline card: 24 registered trials from official public datasets.Report a data error.